Augmedix, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was USD 12.68 million compared to USD 8.75 million a year ago. Net loss was USD 4.49 million compared to USD 5.6 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.225 USD | -10.82% | -17.90% | -61.97% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.97% | 108M | |
+16.20% | 71.05B | |
+7.27% | 17.43B | |
+14.34% | 13.99B | |
+23.04% | 13.75B | |
+17.76% | 10.09B | |
-22.30% | 6.71B | |
-4.35% | 5.99B | |
+1.07% | 5.15B | |
-0.71% | 4.98B |
- Stock Market
- Equities
- AUGX Stock
- News Augmedix, Inc.
- Augmedix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023